We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
- Authors
Liu, Shiwei (Steve); Pickens, Sarah; Burma, Nicole E.; Ibarra-Lecue, Ines; Hongyan Yang; Lihua Xue; Cook, Chris; Hakimian, Joshua K.; Severino, Amie L.; Lueptow, Lindsay; Komarek, Kristina; Taylor, Anna M. W.; Olmstead, Mary C.; Carroll, F. Ivy; Bass, Caroline E.; Andrews, Anne M.; Walwyn, Wendy; Trang, Tuan; Evans, Christopher J.; Leslie, Frances M.
- Abstract
Pain is a multidimensional experience and negative affect, or how much the pain is "bothersome", significantly impacts the sufferers' quality of life. It is well established that the k opioid system contributes to depressive and dysphoric states, but whether this system contributes to the negative affect precipitated by the occurrence of chronic pain remains tenuous. Using a model of persistent pain, we show by quantitative real-time-PCR, florescence in situ hybridization, Western blotting and GTPgS autoradiography an upregulation of expression and the function of k opioid receptors (KORs) and its endogenous ligand dynorphin in the mesolimbic circuitry in animals with chronic pain compared with surgical controls. Using in vivo microdialysis and microinjection of drugs into the mesolimbic dopamine system, we demonstrate that inhibiting KORs reinstates evoked dopamine release and reward-related behaviors in chronic pain animals. Chronic pain enhanced KOR agonist-induced place aversion in a sex-dependent manner. Using various place preference paradigms, we show that activation of KORs drives pain aversive states in male but not female mice. However, KOR antagonist treatment was effective in alleviating anxiogenic and depressive affective-like behaviors in both sexes. Finally, ablation of KORs from dopamine neurons using AAV-TH-cre in KORloxP mice prevented pain-induced aversive states as measured by place aversion assays. Our results strongly support the use of KOR antagonists as therapeutic adjuvants to alleviate the emotional, tonic-aversive component of chronic pain, which is argued to be the most significant component of the pain experience that impacts patients' quality of life.
- Publication
Journal of Neuroscience, 2019, Vol 39, Issue 21, p4162
- ISSN
0270-6474
- Publication type
Article
- DOI
10.1523/JNEUROSCI.0274-19.2019